Brief: Trevena Announces Initiation Of Proof-Of-Concept Study For TRV734 For Potential Treatment Of Opioid Use Disorder
Dec 23 (Reuters) - Trevena Inc TRVN.O :
* TREVENA ANNOUNCES INITIATION OF PROOF-OF-CONCEPT STUDY FOR
TRV734 FOR POTENTIAL TREATMENT OF OPIOID USE DISORDER
Source text for Eikon: ID:nGNX9vzF51
Further company coverage: TRVN.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Trevena
See all newsTrevena Inc reports results for the quarter ended in June - Earnings Summary
Trevena Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Trevena Q2 EPS USD -0.23
Brief: Trevena Announces $2M Non-Dilutive Financing Tranche And Reduction In Outstanding Liabilities In Connection With Existing Ex-Us Royalty Financing
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone